Latest Headlines

Latest Headlines

Quintiles tweaks Apple's ResearchKit for use in biopharma-sponsored trials

Quintiles has made changes to Apple's open-source ResearchKit framework. The CRO made the enhancements--the code for which it released on the GitHub repository--to make Apple's platform more suitable for the trials it oversees.

Quintiles lends its data-crunching know-how to Apple's ResearchKit

Quintiles has contributed some open-source code to improve Apple's ResearchKit project, a platform designed to help physicians and scientists gather medical data from millions of patients.

Quintiles founder stepping down as chairman after 33 years

Quintiles founder Dennis Gillings is set to vacate his chairmanship at the end of 2015, ending a 33-year tenure at the top that saw the North Carolina company grow into the world's biggest CRO.

Quintiles upgrades Apple ResearchKit with open source additions

Quintiles has contributed open-source enhancements to Apple's ResearchKit, adding more sophisticated application features beyond the basic three modules first introduced by Apple in March. The CRO plans to develop patient engagement ResearchKit-based apps for use in its own clinical trials with a particular focus on neurodegenerative diseases including dementia.

Quintiles narrows its outlook after another positive quarter

CRO giant Quintiles posted another $1 billion revenue quarter on the way to a record year, but the company is narrowing its sales projections over ongoing foreign exchange issues.

Quintiles pairs up with IMS to use real-world data in post-market studies

Quintiles signed a deal with healthcare information giant IMS Health to pair its own clinical development expertise with its partner's huge trove of real-world data, planning to use anonymized patient information to steer drug trials.

Quintiles shuffles its C-suite with new CFO, COO

Quintiles, the world's largest CRO, is promoting a new chief operating officer from within and bringing on an external chief financial officer as the company rolls toward a record revenue year.

Quintiles' $950M IPO keeps on giving for PE backers

Two years after Quintiles' trend-setting IPO, the CRO's private equity owners are still profiting from the company's continued growth, pocketing $545 million in a secondary offering.

Quintiles restores its rosy outlook after a big quarter

Quintiles is going back to its earlier optimism for 2015, scaling up its previously reduced growth projections after posting a strong sales quarter.

Quest and Quintiles rev up new lab testing JV

Quest Diagnostics is charging full speed ahead with its previously announced joint venture with global CRO Quintiles, launching the companies' new business, dubbed Q2 Solutions, to provide lab services for clinical trials and to expand its diagnostics footprint.